Production (Stage)
Hoth Therapeutics, Inc.
HOTH
$1.19
-$0.11-8.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.90M | 4.97M | 4.69M | 4.57M | 4.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.64M | 8.32M | 7.90M | 7.86M | 7.92M |
| Operating Income | -9.64M | -8.32M | -7.90M | -7.86M | -7.92M |
| Income Before Tax | -9.62M | -8.29M | -7.87M | -7.83M | -8.07M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.62 | -8.29 | -7.87 | -7.83 | -8.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.62M | -8.29M | -7.87M | -7.83M | -8.07M |
| EBIT | -9.64M | -8.32M | -7.90M | -7.86M | -7.92M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.15 | -1.36 | -1.48 | -1.77 | -2.10 |
| Normalized Basic EPS | -0.72 | -0.85 | -0.93 | -1.11 | -1.28 |
| EPS Diluted | -1.15 | -1.36 | -1.48 | -1.77 | -2.10 |
| Normalized Diluted EPS | -0.72 | -0.85 | -0.93 | -1.11 | -1.28 |
| Average Basic Shares Outstanding | 33.82M | 25.49M | 22.54M | 19.12M | 15.54M |
| Average Diluted Shares Outstanding | 33.82M | 25.49M | 22.54M | 19.12M | 15.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |